|
SN-NJ-R169
N/A |
|
Composite hydrogel containing doxorubicin chondroitin sulfate nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R170
N/A |
|
PLGA-PEG nanoparticle composite hydrogel loaded with cisplatin
|
￥Member visible
|
|
|
SN-NJ-R171
N/A |
|
Temozolomide nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R172
N/A |
|
Ropivacaine PLGA Nanoparticle Composite Hydrogel
|
￥Member visible
|
|
|
SN-NJ-R173
N/A |
|
Hepatitis B vaccine nanoparticle composite hydrogel coated with protamine
|
￥Member visible
|
|
|
SN-NJ-R174
N/A |
|
Composite hydrogel containing ICG nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R175
N/A |
|
Folic acid-loaded capecitabine nanospheres
|
￥Member visible
|
|
|
SN-NJ-R176
N/A |
|
PLGA nanoparticle composite hydrogel containing doxorubicin and siRNA
|
￥Member visible
|
|
|
SN-NJ-R177
N/A |
|
PLGA/chitosan drug-loaded nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R178
N/A |
|
Composite hydrogel containing vincristine/curcumin nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R179
N/A |
|
5-fluorouracil nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R180
N/A |
|
PLGA magnetic embolization microsphere composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R181
N/A |
|
VCAM-1 targeting nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R182
N/A |
|
Tanshinone nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R184
N/A |
|
TPGS/PLGA nanoparticle composite hydrogel containing interference mitochondria
|
￥Member visible
|
|
|
SN-NJ-R185
N/A |
|
Lymphatic targeting siRNA carrier composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R186
N/A |
|
Targeted DNA liposome composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R187
N/A |
|
Peptide-mediated miRNA carrier composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R188
N/A |
|
RNA-loaded mimic liposome composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R189
N/A |
|
SpCas9 gene-edited liposome composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R190
N/A |
|
MiRNA liposome composite hydrogel for eyes
|
￥Member visible
|
|
|
SN-NJ-R191
N/A |
|
SiRNA liposome composite hydrogel for eyes
|
￥Member visible
|
|
|
SN-NJ-R192
N/A |
|
RNA mimic liposome composite hydrogel for eyes
|
￥Member visible
|
|
|
SN-NJ-R193
N/A |
|
Lymphatic targeting siRNA vesicle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R194
N/A |
|
SpCas9 gene-edited hydrogel
|
￥Member visible
|
|
|
SN-NJ-R195
N/A |
|
Cationic nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R196
N/A |
|
Gene editing functional vector immune hydrogel
|
￥Member visible
|
|
|
SN-NJ-R197
N/A |
|
SiRNA-carrying chitosan carrier composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R198
N/A |
|
Cisplatin and siRNA liposome composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R199
N/A |
|
Fluorouracil-loaded siRNA liposome composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R201
N/A |
|
30℃ temperature sensitive hydrogel
|
￥Member visible
|
|
|
SN-NJ-R202
N/A |
|
Local long-acting sustained-release vaccine hydrogel
|
￥Member visible
|
